7.1.2022
According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…
News
29.12.2021
2021 is an innovative and foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…
9.12.2021
Helsinki – December 9, 2021 – MVision AI, the leading software service provider of guideline-based AI segmentation, GBAIS™, for radiotherapy treatment planning, declares a new distribution partnership with Medron Medical Systems, Canada’s choice health equipment provider (subject to approval from Health Canada). (more…)
News, Press Releases
3.12.2021
 60-70% of cancer patients receive some type of radiation therapy. For some cancers, radiation therapy alone is an effective treatment. The purpose of radiotherapy is to destroy cancer cells and slow tumor growth while limiting the harm to nearby healthy tissue. When it is not possible to destroy all of…
24.11.2021
Stereotactic body radiotherapy (SBRT), or stereotactic ablative body radiotherapy (SABR), is an innovative radiation therapy technique. The technique uses special equipment to precisely deliver a dose of radiation to a tumor. SBRT aims to employ the highest possible dose of radiation to kill cancer while minimizing damage to surrounding tissues…
5.11.2021
Helsinki - 5th of November, 2021 - MVision AI, the pioneer of SaaS radiotherapy treatment planning optimization, announces their distribution partnership YourRad AB, the prime supplier of radiation treatment products for Nordic Clinics. The commitment authorizes YourRad AB with the entitlement to distribute products and services of MVision AI in…
Press Releases
Subscribe to get information, latest news and other interesting offers about MVision AI
